<html>
<head>
<title>Startup Battlefield winner Cellino grabs $80M Series A • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">初创企业战地赢家 Cellino 获得 8000 万美元 A 轮 TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2022/01/25/startup-battlefield-winner-cellino-grabs-80m-series-a/amp/">https://web.archive.org/web/https://techcrunch.com/2022/01/25/startup-battlefield-winner-cellino-grabs-80m-series-a/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg 1920w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=150,84 150w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=300,169 300w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=768,432 768w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=680,383 680w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=1536,864 1536w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=1200,675 1200w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=50,28 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/38c5dd1378cb2d12efb8b47a88a5fb27.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg 1920w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=150,84 150w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=300,169 300w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=768,432 768w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=680,383 680w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=1536,864 1536w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=1200,675 1200w, https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?resize=50,28 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20221112051746im_/https://techcrunch.com/wp-content/uploads/2022/01/Cellino_View_V01B-1.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong>切利诺</p><p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Cellino Bio 的创始人</span> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Nabiha Saklayen </span> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">最初并没有打算进入 TechCrunch Disrupt 2021 的创业战场——是她的公关顾问将创业公司的名字作为通配符条目扔进了戒指。但是在为团队忙碌了一个周末之后，塞利诺还是带着</span> <a href="https://web.archive.org/web/20221112051746/https://techcrunch.com/2021/09/23/and-the-winner-of-startup-battlefield-at-disrupt-2021-is-cellino/#:~:text=Winner%3A%20Cellino&amp;text=Cellino%2C%20a%20company%20developing%20a,cells%20while%20also%20increasing%20yields."> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">的奖品</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">离开了。仅仅几个月之后，Cellino 就有了更大的动力，获得了 8000 万美元的首轮融资</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Cellino 正在寻求自动化我们用来创造人类细胞的过程，最具体地说，是诱导多能干细胞(iPSCs)。IPSCs 由血细胞等其他细胞类型制成，然后转化回干细胞，干细胞最终可以分化成许多不同的细胞类型。TechCrunch 的 Sarah Perez 在这里</span>  <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">报道了 Cellino 的最初推介和概述</span> <a href="https://web.archive.org/web/20221112051746/https://techcrunch.com/2021/09/22/cellino-is-using-ai-and-machine-learning-to-scale-production-of-stem-cell-therapies/"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">，但简而言之，他们的自主过程将允许科学家在再生医学领域产生大量高质量的 iPSCs 和放大研究。这是医学的一个新领域，基于细胞的新疗法有助于身体再生被疾病和衰老损坏的组织。</span></a></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">此轮 A 轮由拜耳、8VC、洪堡基金领投。该轮投资还包括 Felicis Ventures、其他未具名投资者和现有投资者 The Engine 和 Khosla </span> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Ventures。根据公司新闻稿，到目前为止，Cellino 的总资金为 9600 万美元。</span></p>
<p class="translated">再生医学在一些科学领域显示出有趣的进展。例如，根据 Vertex Pharmaceuticals 进行的临床试验，胚胎干细胞衍生的 <a href="https://web.archive.org/web/20221112051746/https://www.nytimes.com/2021/11/27/health/diabetes-cure-stem-cells.html" target="_blank" rel="noopener"> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">胰岛细胞</span> </a> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">已经能够恢复一名糖尿病患者的胰岛素生产能力。但并非来自胚胎的多能干细胞也取得了显著进展。例如，科学家已经将 iPSCs 植入一名帕金森氏症患者体内。</span><a href="https://web.archive.org/web/20221112051746/https://www.nejm.org/doi/full/10.1056/NEJMoa1915872" target="_blank" rel="noopener"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"/></a><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">到目前为止，还没有出现免疫排斥的迹象，科学家们报告说，某些帕金森症状有所改善——但这项研究没有对照组，所以这些发现还非常不成熟。</span></p>
<p class="translated"><amp-iframe src="https://web.archive.org/web/20221112051746if_/https://player.simplecast.com/7dade439-d1b1-4d29-b471-fc80d9b5feb0?dark=false" frameborder="0" scrolling="no" layout="fixed-height" sandbox="allow-scripts allow-same-origin" class="i-amphtml-layout-fixed-height i-amphtml-layout-size-defined" i-amphtml-layout="fixed-height"> <span placeholder="" class="amp-wp-iframe-placeholder"/> <noscript/> </amp-iframe></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">与此同时，在国家眼科研究所，由 Kapil Bharti 领导的一组科学家一直在从患者血液样本中制造诱导多能干细胞，并在动物研究中显示</span><a href="https://web.archive.org/web/20221112051746/https://www.science.org/doi/10.1126/scitranslmed.aat5580" target="_blank" rel="noopener"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"/></a><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">，这些细胞可以与视网膜整合。这表明他们可能能够恢复某些类型的视力丧失，而这些视力丧失目前还无法治疗。</span></p>
<p class="translated">但是，仍然有一个问题似乎主导着再生细胞的研究前景: <i> <span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">你实际上是从哪里获得细胞的？</span> </i></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Cellino 正在寻求大规模扩大 iPSCs 的制造方式。为动物甚至早期人类研究手工制造一些细胞是一回事。但是随着更大规模的 III 期试验的临近，研究人员将需要以可靠的方式制造大量这种细胞的方法。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Cellino 的关键发明是一种基于激光的细胞编辑系统，可以帮助消除无法完成再生组织任务的细胞，或提供先进制造所需的生物货物。与此同时，该公司正在开发能够挑选出不合格细胞的机器学习算法。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">总之，Cellino 正在寻求创建一个闭环系统，可以制造 IPSCs，并消除不可用的-所有这些都无需人工干预。梦想是到 2025 年建立一个真正自主的人类细胞铸造厂。</span></p>
<p class="translated">“你真的遇到了制造瓶颈，”Saklayen 告诉 TechCrunch。“因此，当我们与投资者接触时——他们中的许多人对 iPSC 领域充满热情，并投资了在该领域工作的其他公司——吸引他们到 Cellino 的是我们自动化这些复杂流程的能力。”</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">自从 Disrupt 以来，Cellino 一直在与 Bharti 在国家眼科研究所的项目合作。这是第一次旨在将个性化 iPSCs 移植到患者视网膜的临床试验，有望治疗年龄相关性黄斑变性。</span></p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc"> Cellino 将为即将到来的试验制造 ipsc，Bharti 的团队将测试这些 ipsc，以确保它们符合 FDA 的安全要求。从长远来看，Cellino 的目标是开发 iPSC 衍生的视网膜色素上皮产品。(Saklayen 说，Bharti 也是 Cellino 科学顾问委员会的成员)。截至目前，塞利诺正处于“合作正式化的过程中”，她说。</span></p>

<p class="translated">至于 A 系列，Saklayen 在招聘方面有明确的目标。她将计划扩展平台的机器学习能力——这是让 Cellino 的平台真正自主的关键部分。在科学方面，该公司将通过创建一个强大的数据集来衡量其进展，该数据集将其干细胞与从现有但速度较慢的技术中获得的干细胞进行比较。</p>
<p class="translated"><span data-amp-original-style="font-weight: 400;" class="amp-wp-fe3f5cc">“我们将与已经进入临床试验的(细胞)株进行正面比较，”Saklayen 说。“因此，这是一个真正的可比性数据集，我们要证明来自单一平台的细胞是安全和高质量的。”</span></p>
<p class="translated"><em> Cellino <a href="https://web.archive.org/web/20221112051746/https://techcrunch.com/2021/11/15/how-one-founder-tapped-lasers-to-automate-and-scale-stem-cell-production/">创始人兼首席执行官 Nabiha Saklayen 最近加入了我们的 Found 播客</a>；一定要去看看，了解更多关于她和公司的情况。</em></p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20221112051746im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
	<amp-pixel src="https://web.archive.org/web/20221112051746im_/https://pixel.wp.com/g.gif?v=ext&amp;blog=136296444&amp;post=2261191&amp;tz=-8&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>